School of Medicine
Showing 1-8 of 8 Results
-
Peter R. Egbert, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsOcular pathology of shaken baby syndrome
-
Kasra Eliasieh, MD
Clinical Instructor, Ophthalmology
BioDr. Eliasieh is a fellowship-trained, board-certified ophthalmologist at the Stanford Health Care Byers Eye Institute and the Oculoplastic and Orbital Surgery Program. He is also a clinical assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Eliasieh specializes in lacrimal (tear duct) and orbital (eye socket) surgery, eyelid surgery, and brow lifts. His research includes the study of eye changes during aging and how moderate to severe thyroid eye disease responds to tocilizumab, a biologic medication.
Dr. Eliasieh’s writing and research appear in publications including Ophthalmic Plastic and Reconstructive Surgery, Cornea, and Proceedings of the National Academy of Sciences. He has also presented his research at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Annual Fall Scientific Symposium.
Dr. Eliasieh is a member of ASOPRS and the American Academy of Ophthalmology. -
Houri Esmaeilkhanian
Visiting Instructor, Ophthalmology Research/Clinical Trials
BioDr. Esmaeilkhanian is an accomplished medical doctor who graduated from Iran University of Medical Sciences (IUMS) in 2018. Her passion for ophthalmology ignited during her medical studies, leading her to a focused research career in this field. After earning her degree, she dedicated her efforts to serving underprivileged communities while continuing her research at the Eye and Ear Research Institute of IUMS. In 2021, she advanced to the Doheny Eye Institute at UCLA, working in Prof. Vas Sadda’s lab, where she made significant contributions to research on diabetic retinopathy and age-related macular degeneration (AMD), further honing her clinical expertise. In March 2023, Dr. Esmaeilkhanian joined Byers Eye Institute, pioneering treatments for corneal injuries using innovative stem cell therapies and hydrogels. Additionally, she plays a crucial role in collaborative clinical studies involving the first FDA-approved AI device for diagnosing diabetic retinopathy impacting patient care in both the Bay Area and underserved regions.
